Experts at HLTH Europe discussed how to ensure patients have trust in the EHDS to ensure a successful roll-out.

egnite has launched the CardioCare Research Suite, an advanced component of its flagship platform, aimed at enhancing patient identification processes for cardiovascular clinical trials. This tool is ...

Pfizer's recent trial termination makes it yet another company facing challenges with CD47 studies in oncology.

FELIQS has concluded a $9m Series A funding round, a significant step towards advancing the FLQ-101 clinical programme for ROP.